TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

Name: TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma
License: Public Domain

Sun Yat-sen University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

nasopharyngeal cancinoma (npc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 325307
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.